Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (31-40 of 352) with videos related to

Pageof 36
Sort By:
Cancer Immunology, Immunotherapy : CII|July 28, 2016
Concepts in glioma immunotherapyMichael Platten, Lukas Bunse, Wolfgang Wick, et al.
Oncoimmunology|May 13, 2015
Mutant IDH1: An immunotherapeutic target in tumorsTheresa Schumacher, Lukas Bunse, Wolfgang Wick, et al.
Current Opinion in Neurology|October 7, 2017
The promises of immunotherapy in gliomasIris Mildenberger, Lukas Bunse, Katharina Ochs, et al.
Current Opinion in Neurology|October 5, 2011
Geriatric neuro-oncology: from mythology to biologyMichael Weller, Michael Platten, Patrick Roth, et al.
Der Nervenarzt|May 16, 2019
[Treatment-associated neurological symptoms of cancer patients and their treatment]Iris Mildenberger, Philipp Eisele, Ralf Hofheinz, et al.
Current Opinion in Oncology|August 14, 2018
Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomasMirco Friedrich, Lukas Bunse, Wolfgang Wick, et al.
Cancer Research|October 24, 2012
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletionMichael Platten, Wolfgang Wick, Benoît J Van den Eynde
Nature Nanotechnology|August 26, 2024
Bottom-up synthetic immunologyKerstin Göpfrich, Michael Platten, Friedrich Frischknecht, et al.
Biomedicines|July 27, 2022
Site-Specific Considerations on Engineered T Cells for Malignant GliomasNirmeen Elmadany, Obada T Alhalabi, Michael Platten, et al.
International Journal of Molecular Sciences|December 10, 2021
Genetically Modified Cellular Therapies for Malignant GliomasMichael Kilian, Theresa Bunse, Wolfgang Wick, et al.
Pageof 36

Showing results (31-40 of 352) with videos related to

Sort By:
Pageof 36
Cancer Immunology, Immunotherapy : CII|July 28, 2016
Concepts in glioma immunotherapyMichael Platten, Lukas Bunse, Wolfgang Wick, et al.
Oncoimmunology|May 13, 2015
Mutant IDH1: An immunotherapeutic target in tumorsTheresa Schumacher, Lukas Bunse, Wolfgang Wick, et al.
Current Opinion in Neurology|October 7, 2017
The promises of immunotherapy in gliomasIris Mildenberger, Lukas Bunse, Katharina Ochs, et al.
Current Opinion in Neurology|October 5, 2011
Geriatric neuro-oncology: from mythology to biologyMichael Weller, Michael Platten, Patrick Roth, et al.
Der Nervenarzt|May 16, 2019
[Treatment-associated neurological symptoms of cancer patients and their treatment]Iris Mildenberger, Philipp Eisele, Ralf Hofheinz, et al.
Current Opinion in Oncology|August 14, 2018
Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomasMirco Friedrich, Lukas Bunse, Wolfgang Wick, et al.
Cancer Research|October 24, 2012
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletionMichael Platten, Wolfgang Wick, Benoît J Van den Eynde
Nature Nanotechnology|August 26, 2024
Bottom-up synthetic immunologyKerstin Göpfrich, Michael Platten, Friedrich Frischknecht, et al.
Biomedicines|July 27, 2022
Site-Specific Considerations on Engineered T Cells for Malignant GliomasNirmeen Elmadany, Obada T Alhalabi, Michael Platten, et al.
International Journal of Molecular Sciences|December 10, 2021
Genetically Modified Cellular Therapies for Malignant GliomasMichael Kilian, Theresa Bunse, Wolfgang Wick, et al.
Pageof 36